Jeil Pharmaceutical Co.,Ltd (KRX:271980)
South Korea · Delayed Price · Currency is KRW 10,740
-250 (-2.27%)
Jun 4, 2026, 12:35 PM KST
KRX:271980 Revenue
Jeil Pharmaceutical Co.,Ltd had revenue of 130.30B KRW in the quarter ending March 31, 2026, a decrease of -20.07%. This brings the company's revenue in the last twelve months to 534.52B, down -23.33% year-over-year. In the year 2025, Jeil Pharmaceutical Co.,Ltd had annual revenue of 567.24B, down -19.49%.
Revenue (ttm)
534.52B
Revenue Growth
-23.33%
P/S Ratio
0.30
Revenue / Employee
564.43M
Employees
947
Market Cap
160.14B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 567.24B | -137.30B | -19.49% |
| Dec 31, 2024 | 704.54B | -21.85B | -3.01% |
| Dec 31, 2023 | 726.39B | 4.16B | 0.58% |
| Dec 31, 2022 | 722.23B | 21.54B | 3.07% |
| Dec 31, 2021 | 700.69B | 9.37B | 1.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Daewon Pharmaceutical | 605.66B |
| Dongwha Pharm.Co.,Ltd | 501.33B |
| Ilyang Pharmaceutical Co.,Ltd | 275.51B |
| JW Lifescience | 252.72B |
| HLB Pharmaceutical | 236.59B |
| Daihan Pharmaceutical | 211.44B |
| Samil Pharmaceutical Co.,Ltd | 210.51B |
| Hana Pharm | 139.33B |